Today, Latent Labs launches Latent-Y, an AI agent that autonomously designs therapeutic antibodies from a text prompt, compressing weeks of expert work into hours. Powered by Latent-X2, Latent Labs' ...
In this interview conducted at SLAS EU 2023 in Brussels, Belgium, we spoke to Garry Pairaudeau, Chief Technology Officer at Exscientia*, about pharmatech, AI, and more. My name is Garry Pairaudeau, ...
AZoLifeSciences on MSN
PairMap Method Reduces Drug Discovery Costs and Improves Binding Predictions
Drug discovery is a costly and time-intensive process, with binding free energy calculations between the potential drug ...
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and ...
A team of chemists has unveiled a novel method to simplify the synthesis of piperidines, a key structural component in many pharmaceuticals. The study combines biocatalytic carbon-hydrogen oxidation ...
TOKYO--(BUSINESS WIRE)--Elix, Inc. (CEO: Shinya Yuki / Headquarters: Tokyo; hereinafter “Elix”) is pleased to announce that its AI drug discovery platform, Elix ...
The FDA has released a draft guidance outlining how drug developers can validate new approach methodologies (NAMs) as alternatives to animal testing in preclinical drug development. The guidance, ...
Disease modeling and target identification are critical and time-consuming portions of the drug discovery process and areas where artificial intelligence (AI) is already making a substantial impact. A ...
Schrödinger (SDGR) and Revvity (RVTY) on Friday announced collaborations with Eli Lilly (LLY) to integrate their respective drug development software offerings with the Indiana-based pharma giant’s ...
Explore the potential of light-driven chemistry to revolutionize drug design, making it safer and more efficient.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results